Patents-Review.com
ClassID:

94987 ⎘

C07D307/64 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Sulfur atoms

Recent Application in this class:
#1
20260063994
2026-03-05

RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN AND ONIUM SALT COMPOUND

 #2
20250388568
2025-12-25

NLRP3 INHIBITORS

 #3
20250346557
2025-11-13

METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP

 #4
20240400502
2024-12-05

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

 #5
20240253023
2024-08-01

PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS

 #6
20240066002
2024-02-29

Nitroxyl donors with improved therapeutic index

 #7
20230416213
2023-12-28

SURFACTANTS

 #8
20230416211
2023-12-28

Compounds and compositions for treating conditions associated with NLRP activity

 #9
20230150927
2023-05-18

Cannabigerol derivatives and use thereof as cannabinoid receptor modulators

 #10
20230134776
2023-05-04

Cannabinoid derivatives

 #11
20230132093
2023-04-27

EXTRACELLULAR VESICLE-NLRP3 ANTAGONIST

 #12
20230099258
2023-03-30

Compounds and compositions for treating conditions associated with NLRP activity

 #13
20230063462
2023-03-02

SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

 #14
20230062815
2023-03-02

Compounds and compositions for treating conditions associated with NLRP activity

 #15
20230051589
2023-02-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

 #16
20220411392
2022-12-29

Amide derivative and preparation method therefore and use thereof in medicine

 #17
20220388953
2022-12-08

COMPOUNDS WITH ANTIMICROBIAL ACTIVITY

 #18
20220387397
2022-12-08

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

 #19
20220380325
2022-12-01

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

 #20
20220259144
2022-08-18

Compounds as NLRP3 inflammasome inhibitors and compositions and uses thereof

 #21
20220251036
2022-08-11

DIFLUOROHALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES, METHODS OF PREPARATION, AND USES THEREOF

 #22
20220204467
2022-06-30

Furan surfactant compositions and methods

 #23
20220193026
2022-06-23

Nitroxyl donors with improved therapeutic index

 #24
20220112159
2022-04-14

Sulfonylureas and related compounds and use of same

 #25
20210171477
2021-06-10

Compounds and compositions for treating conditions associated with NLRP activity

 #26
20210139444
2021-05-13

Surfactants from long-chain carbon-containing molecules

 #27
20210015784
2021-01-21

Nitroxyl donors with improved therapeutic index

 #28
20200407335
2020-12-31

Surfactants from long-chain carbon-containing molecules

 #29
20200308475
2020-10-01

Oleofuransulfonate surfactants for use in wellbore applications

 #30
20200247763
2020-08-06

Androgen receptor modulators and methods for their use

 #31
20200163929
2020-05-28

Pharmaceutical compositions comprising nitroxyl donors

 #32
20200140382
2020-05-07

Substituted sulfoximine compounds

 #33
20200123117
2020-04-23

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

 #34
20200121633
2020-04-23

Nitroxyl donors with improved therapeutic index

 #35
20200109110
2020-04-09

Sulfur derivatives as chemokine receptor modulators

 #36
20200087270
2020-03-19

Compounds and compositions for treating conditions associated with NLRP activity

 #37
20200039929
2020-02-06

2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase

 #38
20200031816
2020-01-30

Heteroaryl compound, enantiomer, diastereomer or pharmaceutically acceptable salt thereof, and antiviral composition containing same as active ingredient

 #39
20190359564
2019-11-28

Sulfonylureas and related compounds and use of same

 #40
20190224159
2019-07-25

Pharmaceutical compositions comprising nitroxyl donors

 #41
20190133990
2019-05-09

Nitroxyl donors with improved therapeutic index

 #42
20190119241
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

 #43
20190119224
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

 #44
20190119203
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

 #45
20190091183
2019-03-28

Redox-activated pro-chelators

 #46
20190036168
2019-01-31

Electrolyte and electrochemical energy storage device

 #47
20180327376
2018-11-15

Methods of forming aromatic containing compounds

 #48
20180327375
2018-11-15

Aromatic surfactants

 #49
20180271097
2018-09-27

HETEROCYCLIC TRIFLUOROALKENYL COMPOUNDS HAVING A NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF

 #50
20180235927
2018-08-23

Nitroxyl donors with improved therapeutic index

 #51
20180044287
2018-02-15

Sulfonylureas and related compounds and use of same

 #52
20170334841
2017-11-23

TETRACYCLINE COMPOUNDS

 #53
20170183333
2017-06-29

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

 #54
20170050925
2017-02-23

Sulfur derivatives as chemokine receptor modulators

 #55
20170044109
2017-02-16

Sulfonyl hydrazide compounds and a regio-selective process to prepare 4-aroyl pyrazole derivatives

 #56
20160370700
2016-12-22

Photoresist composition, compound, and production method thereof

 #57
20160362535
2016-12-15

5H-furan-2-one derivatives stabilization of organic material

 #58
20160318861
2016-11-03

Prodrugs of dithiol mucolytic agents

 #59
20160221938
2016-08-04

Bisarylsulfonamides useful in the treatment of inflammation and cancer

 #60
20160083342
2016-03-24

Sulfur derivatives as chemokine receptor modulators

 #61
20160031807
2016-02-04

Nitroxyl donors with improved therapeutic index

 #62
20150366977
2015-12-24

Pharmaceutical compositions comprising nitroxyl donors

 #63
20150289505
2015-10-15

Herbicide composition

 #64
20150210635
2015-07-30

Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient

 #65
20150175566
2015-06-25

Nitroxyl donors with improved therapeutic index

 #66
20150141255
2015-05-21

Strigolactone analogues and the use thereof for the treatment of plants

 #67
20150025068
2015-01-22

Bisarylsulfonamides useful in the treatment of inflammation and cancer

 #68
20150004545
2015-01-01

Photoresist composition, compound, and production method thereof

 #69
20140378466
2014-12-25

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

 #70
20140221481
2014-08-07

Sulfur derivatives as chemokine receptor modulators

 #71
20140206769
2014-07-24

Nitroxyl donors with improved therapeutic index

 #72
20140058021
2014-02-27

5H-furan-2-one derivatives for stabilization of organic material

 #73
20130345446
2013-12-26

Method for preparing a furfuranol-based compound and 2-furancarboxylic acid-based compound using an ionic liquid as a solvent

 #74
20130261120
2013-10-03

Substituted N-(2-arylamino)aryl sulfonamide-containing combinations

 #75
20130252984
2013-09-26

Sulfur derivatives as chemokine receptor modulators

 #76
20130237552
2013-09-12

Sulfur derivatives as chemokine receptor modulators

 #77
20130085068
2013-04-04

Germination-stimulant carbamate derivatives and process for preparation thereof

 #78
20130039945
2013-02-14

Sulfonamide anti-viral compounds

 #79
20130035503
2013-02-07

Sulfonium compound, photoacid generator, and resist composition

 #80
20130012709
2013-01-10

NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES

 #81
20120208788
2012-08-16

Tetracycline compounds

 #82
20120202781
2012-08-09

Indane derivatives

 #83
20120172606
2012-07-05

Sulfonium compound, photo-acid generator, and method for manufacturing the same

 #84
20120157487
2012-06-21

Sulfur derivatives as chemokine receptor modulators

 #85
20120157413
2012-06-21

Phosphorous derivatives as chemokine receptor modulators

 #86
20120095012
2012-04-19

TOLUIDINE SULFONAMIDES AND THEIR USE

 #87
20120022076
2012-01-26

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

 #88
20110319437
2011-12-29

Iminopropene compound and use thereof

 #89
20110201616
2011-08-18

Sulfonamide compounds or salts thereof

 #90
20110144345
2011-06-16

SULFOXYIMINO-SUBSTITUTED BENZOYL DERIVATIVE AND HERBICIDE

 #91
20110034513
2011-02-10

Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production

 #92
20100297541
2010-11-25

SULPHONIUM SALT INITIATORS

 #93
20100197640
2010-08-05

Sulfamoyl-phenyl-ureido compounds and their use as medicament

 #94
20100087437
2010-04-08

Potassium channel blockers

 #95
20100048669
2010-02-25

Therapeutic compounds

 #96
20100041708
2010-02-18

N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation

 #97
20100022773
2010-01-28

Apoptosis promoters

 #98
20100022594
2010-01-28

Heterocyclic sulfonamide inhibitors of beta amyloid production

 #99
20090232935
2009-09-17

Furyl thioalkanals useful in the flavor industry

 #100
20090169985
2009-07-02

ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND

 #101
20090156642
2009-06-18

5-Membered heterocyclic compound

 #102
20090143437
2009-06-04

EPreceptor antagonists

 #103
20090093641
2009-04-09

Synthesis of Pentafluorosulfanyl (SF5)-Substituted Heterocycles and Alkynes

 #104
20090082457
2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

 #105
20080318160
2008-12-25

Sulfonate salts and derivatives, photoacid generators, resist compositions, and patterning process

 #106
20080119538
2008-05-22

Therapeutic compounds

 #107
20080085928
2008-04-10

Sulfonamide derivatives

 #108
20080058340
2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

 #109
20080039502
2008-02-14

EPreceptor antagonists

 #110
20080004323
2008-01-03

Iminopropene compound and use thereof

 #111
20070213407
2007-09-13

Compounds to treat Alzheimer's disease

 #112
20070149577
2007-06-28

Compounds with medicinal effects due to interaction with the glucocorticoid receptor

 #113
20070123575
2007-05-31

EPreceptor antagonists

 #114
20070021495
2007-01-25

SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR

 #115
20060228648
2006-10-12

Sulfonate salts and derivatives, photoacid generators, resist compositions, and patterning process

 #116
20060173058
2006-08-03

KCNQ channel modulating compounds and their pharmaceutical use

 #117
20060094893
2006-05-04

Process for preparing cyclic carbonates

 #118
20060030713
2006-02-09

N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation

 #119
20060025445
2006-02-02

11-Beta HSD1 inhibitors

 #120
20060009528
2006-01-12

Cannabinoid receptor ligands

 #121
20060004063
2006-01-05

Inhibitors of HCV NS5B polymerase

 #122
20050240060
2005-10-27

Low loss high refractive index vinyl sulfide compounds and method of making same

 #123
20050196813
2005-09-08

Heterocyclic sulfonamide inhibitors of β amyloid production

 #124
20050159427
2005-07-21

N-acylsulfonamide apoptosis promoters

 #125
20050124672
2005-06-09

N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation

 #126
20050123831
2005-06-09

Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials

 #127
20050074668
2005-04-07

Perfluorinated amide salts and their uses as ionic conducting materials

 #128
20050023507
2005-02-03

Nonlinear optical compounds and methods for their preparation